The DEGs included genes involved in cell proliferation and migration (e.g., COL11A1), tumor‐promoting factors that degrade the extracellular matrix (e.g., MMP11), as well as immunosuppressive (TGFB1) and proinflammatory responses (TNFRSF6B, IFNGR2, GSDMB) (Table S2) (Figure 2A) [19, 20, 21, 22]. The gene discussed is MMP11; the disease is neoplasm.